Preeclampsia Circulating and Placental Growth-Differentiation Factor 15 in Preeclampsia and in Pregnancy Complicated by Diabetes Mellitus

Growth-differentiation factor 15 (GDF-15), a stress-responsive transforming growth factor–related cytokine, is emerging as a new risk marker in patients with cardiovascular disease. We explored GDF-15 in preeclampsia and in diabetic pregnancies, because these conditions are associated with augmented risk for cardiovascular disease, both in mother and in offspring. Plasma from pregnant women (n 267; controls: n 59, preeclampsia: n 85, diabetes mellitus: n 112, and superimposed preeclampsia in diabetes mellitus: n 11), fetal plasma (n 72), and amniotic fluid (n 99) were analyzed by immunoassay for GDF-15. Placental GDF-15 mRNA and protein expression levels were analyzed by quantitative real-time PCR and immunoblots in 78 and 18 pregnancies, respectively. Conditioned media from preeclamptic (n 6) and control (n 6) villous placenta explants were analyzed by immunoassay for GDF-15. Median maternal GDF-15 concentration was elevated in those with diabetes mellitus, as compared with controls (91 549 versus 79 875 ng/L; P 0.02). Median GDF-15 concentration was higher in patients with preeclampsia than in controls in term maternal blood samples (127 061 versus 80 319 ng/L; P 0.001). In the fetal circulation and amniotic fluid, GDF-15 was elevated in preeclampsia and superimposed preeclampsia in diabetes mellitus, as compared with controls. GDF-15 placental mRNA expression was elevated in preeclampsia, as compared with controls (P 0.002). Placenta immunoblots confirmed a single GDF-15 protein band, and a time-dependent increase in GDF-15 protein was detected in the conditioned media. Our study is the first to show that GDF-15 is dysregulated, both in preeclampsia and in diabetic pregnancies. The mechanisms and diagnostic implications of these findings remain to be explored. (Hypertension. 2009;54:106-112.)

[1]  D. Merrill,et al.  Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study , 2010, Reproductive biology and endocrinology : RB&E.

[2]  K. Kos,et al.  Identification of macrophage inhibitory cytokine-1 (MIC-1) in adipose tissue and its secretion as an adipokine by human adipocytes , 2009, Proceedings of the Nutrition Society.

[3]  L. Wallentin,et al.  Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. , 2007, European heart journal.

[4]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[5]  R. Harskamp,et al.  Preeclampsia: At Risk for Remote Cardiovascular Disease , 2007, The American journal of the medical sciences.

[6]  D. Charnock-Jones,et al.  Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. , 2007, The American journal of pathology.

[7]  P. Ponikowski,et al.  Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.

[8]  A. Clerk,et al.  Cardiac myocyte gene expression profiling during H2O2-induced apoptosis. , 2007, Physiological genomics.

[9]  G. Wallukat,et al.  Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia , 2007, Hypertension.

[10]  R. Califf,et al.  Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome , 2007, Circulation.

[11]  G. Brabant,et al.  Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. , 2007, Clinical chemistry.

[12]  G. Burton,et al.  Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. , 2006, Taiwanese journal of obstetrics & gynecology.

[13]  A. Barden.  PRE‐ECLAMPSIA: CONTRIBUTION OF MATERNAL CONSTITUTIONAL FACTORS AND THE CONSEQUENCES FOR CARDIOVASCULAR HEALTH , 2006, Clinical and experimental pharmacology & physiology.

[14]  T. Wilsgaard,et al.  Longitudinal reference ranges for estimated fetal weight , 2006, Acta obstetricia et gynecologica Scandinavica.

[15]  T. Hewett,et al.  GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein Activation , 2006, Circulation research.

[16]  H. Drexler,et al.  The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. , 2006, Circulation research.

[17]  M. Olovsson,et al.  The risk of maternal ischaemic heart disease after gestational hypertensive disease , 2005 .

[18]  A. Staff,et al.  Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. , 2005, American journal of obstetrics and gynecology.

[19]  I. Sargent,et al.  Latest Advances in Understanding Preeclampsia , 2005, Science.

[20]  B. Roald,et al.  The decidual suction method: a new way of collecting decidual tissue for functional and morphological studies , 2004, Acta obstetricia et gynecologica Scandinavica.

[21]  L. Myatt,et al.  Oxidative stress in the placenta , 2004, Histochemistry and Cell Biology.

[22]  L. Duley.  Pre-eclampsia and the hypertensive disorders of pregnancy. , 2003, British medical bulletin.

[23]  R. Voutilainen,et al.  Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.

[24]  L. Vatten,et al.  Intrauterine Exposure to Preeclampsia and Adolescent Blood Pressure, Body Size, and Age at Menarche in Female Offspring , 2003, Obstetrics and gynecology.

[25]  S. Breit,et al.  Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. , 2003, Placenta.

[26]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[27]  W. D. Fairlie,et al.  Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study , 2002, The Lancet.

[28]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[29]  W. D. Fairlie,et al.  The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  L. Roberts,et al.  Placental isoprostane is significantly increased in preeclampsia , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  H. Gjessing,et al.  Birthweight by gestational age in Norway , 2000, Acta obstetricia et gynecologica Scandinavica.

[32]  T. Henriksen,et al.  Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia. , 1999, American journal of obstetrics and gynecology.

[33]  N. Schneiderman,et al.  History of gestational diabetes, insulin resistance and coronary risk. , 1999, Journal of diabetes and its complications.

[34]  I. Sargent,et al.  Preeclampsia: An Excessive Maternal Inflammatory Response to Pregnancy , 1999 .

[35]  T. Henriksen,et al.  Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. , 1999, American journal of obstetrics and gynecology.

[36]  W. D. Fairlie,et al.  MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation , 1999, Journal of leukocyte biology.

[37]  L. Weissfeld,et al.  Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. , 1998, Metabolism: clinical and experimental.

[38]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[39]  S. Vukicevic,et al.  Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family* , 1998, The Journal of Biological Chemistry.

[40]  M. Soares,et al.  Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. , 1997, Gene.

[41]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Mihoro Saeki,et al.  Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. , 1997, Journal of biochemistry.

[43]  A. Waage,et al.  Interleukin‐1, interleukin‐6 and tumor necrosis factor at delivery in preeclamptic disorders , 1995, Acta obstetricia et gynecologica Scandinavica.

[44]  James M. Roberts,et al.  Preeclampsia: More Than Pregnancy‐Induced Hypertension , 1994 .

[45]  M. D'Alton,et al.  Preeclampsia in diabetic pregnancies , 1991 .